PROCOS S.P.A. (CBC Group)
Jacopo Roletto has extensive experience in research and development within the pharmaceutical industry, currently serving as the R&D Director at Procos SpA (CBC Group) since March 2007, following roles as R&D Lab Director and R&D Group Leader. Prior to this, Jacopo Roletto worked as an R&D Senior Researcher at ANTIBIOTICOS S.p.A. from 1994 to 2007. Academic credentials include a Master's degree in Organic Synthesis from Università degli Studi di Milano (2002-2004) and a degree in Industrial Chemistry from Università degli Studi di Torino (1988-1993).
PROCOS S.P.A. (CBC Group)
Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry. Our core business sectors include custom synthesis and Generic API manufacturing. The manufacturing site is located in Cameri, Italy. This 110,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA. We are a locally rooted company yet part of an international network, with commercial offices in key strategic geographies.